Tandem reports positive clinical impact of Control-IQ technology on glucose control
The research results, published in the Diabetes Technology & Therapeutics journal, showed a positive clinical impact of the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Apr 23
The research results, published in the Diabetes Technology & Therapeutics journal, showed a positive clinical impact of the…
17 Apr 23
The 30,000m² facility will be Abbott’s seventh manufacturing facility in Ireland, which will manufacture the FreeStyle Libre 3…
17 Apr 23
Failure to use the FreeStyle Libre 3 system as instructed in labeling may result in missing a severe…
31 Mar 23
The technology will determine how people with insulin-requiring diabetes respond to a particular insulin dose, and offers a…
29 Mar 23
The combined solution is intended to manage diabetes by capturing, storing, and transmitting blood glucose data gathered in…
28 Mar 23
Bringing Fully Digitized Experience for Diabetes Patients on Insulin and Adding Another Data Point to Japan's Personal Health…
09 Mar 23
The Sofia 2 SARS Antigen+ FIA is a prescription use only lateral flow immunofluorescent assay that can be…
03 Mar 23
Bigfoot aims to free people from the burdens of living with insulin-requiring diabetes, improve access, and support health…
27 Feb 23
The one-year data from the ADAPT study, which evaluated the safety and efficacy of AHCL therapy, showed that…
24 Feb 23
SoloSmart is a single add-on connected device intended for use with SoloStar and DoubleStar insulin injection pens, to…